Stocks in News: Central European Distribution, Oxygen Biotherapeutics, PharmAthene, Research in Motion

Lakeway, NY -- (SBWIRE) -- 03/11/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Central European Distribution Corp (NASDAQ:CEDC) shares soared 24.88% to $0.500 following news that it entered an amended exchange offer with RTL. The company announced today that the Company and its subsidiary, CEDC Finance Corporation International, Inc. ("CEDC FinCo"), have amended their exchange offers, commenced on February 25, 2013, to reflect terms agreed to and supported by the Company, Roust Trading Ltd. ("RTL"), a major investor in the Company, and a Steering Committee of holders of approximately 30% of the outstanding principal amount of CEDC FinCo's Senior Secured Notes due 2016 (the "2016 Steering Committee").

Is CEDC a Still a Buy after the Solid momentum? Let’s Find out Here

Oxygen Biotherapeutics, Inc.(NASDAQ:OXBT) shares gained 11.34% and closed at $0.333. The company, on Feb. 22, announced that it has entered into definitive agreements with an institutional investor for a financing of up to $2.1 million in gross proceeds. Under the terms of the agreements, Oxygen will issue registered shares of Series B-1 convertible preferred stock (the Series B-1 Stock) for $1.6 million in gross proceeds and unregistered shares of Series B-2 convertible preferred stock (the Series B-2 Stock and, together with the Series B-1 Stock, the Preferred Stock) for $0.5 million in gross proceeds, which are convertible into common stock of the Company at $0.25 per share.

Is OXBT a Strong Buying Opportunity After The Recent Slump? Find out Here

PharmAthene, Inc. (NYSEAMEX:PIP) shares gained 12.35% to $1.82 in the morning hour. Aegis Capital initiated coverage on PIP on Mar. 6 to Buy. The Company operates as a biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological threats.

Should PIP Buy PIP After The Recent Movement? Let’s Find out Here

Research In Motion Ltd (NASDAQ:BBRY) shares increased 10.03% to $14.37. According to the President and CEO of Research In Motion, Thorsten Heins, with its new BB10 operating system, the Canadian phone manufacturer has obtained the ticket that is required to take part in the race, and currently just has to play the game in order to win the trophy for the championship.

Additionally, BBRY) and Lagos State Innovation Advisory Council announced today that they have plans to build a BlackBerry Apps Lab in the state.

Is BBRY a Strong Buying Opportunity After The Recent Slump? Find out Here

About ThePennyStockProfiler.com
ThePennyStockProfiler.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. ThePennyStockProfiler.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at http://www.ThePennyStockProfiler.com

Disclaimer
The assembled information disseminated by ThePennyStockProfiler.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. ThePennyStockProfiler.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.